Literature DB >> 14668784

The quest for myocardial viability: Is there a role for nitrate-enhanced imaging?

Marcelo F Di Carli.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14668784     DOI: 10.1016/j.nuclcard.2003.09.001

Source DB:  PubMed          Journal:  J Nucl Cardiol        ISSN: 1071-3581            Impact factor:   5.952


× No keyword cloud information.
  27 in total

1.  Sensitivity, specificity, and predictive accuracies of various noninvasive techniques for detecting hibernating myocardium.

Authors:  J J Bax; D Poldermans; A Elhendy; E Boersma; S H Rahimtoola
Journal:  Curr Probl Cardiol       Date:  2001-02       Impact factor: 5.200

2.  The art and science of predicting postrevascularization improvement in left ventricular (LV) function in patients with severely depressed LV function.

Authors:  Marcelo F Di Carli; Rory Hachamovitch; Daniel S Berman
Journal:  J Am Coll Cardiol       Date:  2002-11-20       Impact factor: 24.094

3.  The hibernating myocardium.

Authors:  S H Rahimtoola
Journal:  Am Heart J       Date:  1989-01       Impact factor: 4.749

4.  Quantitative analysis of technetium 99m 2-methoxyisobutyl isonitrile single-photon emission computed tomography and isosorbide dinitrate infusion in assessment of myocardial viability before and after revascularization.

Authors:  S T Li; X J Liu; Z L Lu; R F Shi; X D Zhu; W Q Chen; Q W Wu; Y Z Liu
Journal:  J Nucl Cardiol       Date:  1996 Nov-Dec       Impact factor: 5.952

5.  Enhanced detection of viable myocardium by technetium-99m-MIBI imaging after nitrate administration in chronic coronary artery disease.

Authors:  S Maurea; A Cuocolo; A Soricelli; L Castelli; A Nappi; F Squame; M Imbriaco; B Trimarco; M Salvatore
Journal:  J Nucl Med       Date:  1995-11       Impact factor: 10.057

6.  Long-term survival of medically treated patients in the Coronary Artery Surgery Study (CASS) Registry.

Authors:  M Emond; M B Mock; K B Davis; L D Fisher; D R Holmes; B R Chaitman; G C Kaiser; E Alderman; T Killip
Journal:  Circulation       Date:  1994-12       Impact factor: 29.690

7.  Positron emission tomography and recovery following revascularization (PARR-1): the importance of scar and the development of a prediction rule for the degree of recovery of left ventricular function.

Authors:  Rob S B Beanlands; Terrence D Ruddy; Robert A deKemp; Robert M Iwanochko; Geoffrey Coates; Michael Freeman; Claude Nahmias; Paul Hendry; Robert J Burns; Andre Lamy; Lynda Mickleborough; William Kostuk; Ernest Fallen; Graham Nichol
Journal:  J Am Coll Cardiol       Date:  2002-11-20       Impact factor: 24.094

8.  Risk stratification and survival after myocardial infarction.

Authors: 
Journal:  N Engl J Med       Date:  1983-08-11       Impact factor: 91.245

9.  Early and long-term results of coronary artery bypass grafting with severely depressed left ventricular performance.

Authors:  A P Freeman; W F Walsh; R W Giles; D Choy; D C Newman; D A Horton; J S Wright; I P Murray
Journal:  Am J Cardiol       Date:  1984-10-01       Impact factor: 2.778

10.  Results of coronary artery surgery in patients with poor left ventricular function (CASS).

Authors:  E L Alderman; L D Fisher; P Litwin; G C Kaiser; W O Myers; C Maynard; F Levine; M Schloss
Journal:  Circulation       Date:  1983-10       Impact factor: 29.690

View more
  2 in total

1.  Survival benefit after revascularization is independent of left ventricular ejection fraction improvement in patients with previous myocardial infarction and viable myocardium.

Authors:  Wanda Acampa; Mario Petretta; Letizia Spinelli; Marco Salvatore; Alberto Cuocolo
Journal:  Eur J Nucl Med Mol Imaging       Date:  2004-11-20       Impact factor: 9.236

2.  Relation between wall thickening on gated perfusion SPECT and functional recovery after coronary revascularization in patients with previous myocardial infarction.

Authors:  Mario Petretta; Giovanni Storto; Wanda Acampa; Valeria Sansone; Laura Evangelista; Letizia Spinelli; Alberto Cuocolo
Journal:  Eur J Nucl Med Mol Imaging       Date:  2004-07-31       Impact factor: 9.236

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.